Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Sandra Milligan > Profile

Sandra Milligan

Affiliations

  • Director at Spyre Therapeutics Inc. (SYRE), 2025-06-02
  • Interim Ceo at Aspira Women's Health Inc. (AWH), 2025-01-29
  • Director at Gossamer Bio Inc. (GOSS), 2024-06-07
  • Head Of Research & Development at Organon & Co. (OGN), 2023-05-08
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GOSS $0.79 32,000 $25,212.80 32,000 2023-11-15 Filing